These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10389304)

  • 1. [Antiretroviral treatment in 1999: from uncertainty to hopefulness].
    Pujol de la Llave E
    An Med Interna; 1999 May; 16(5):215-7. PubMed ID: 10389304
    [No Abstract]   [Full Text] [Related]  

  • 2. Guide to major clinical trials of antiretroviral therapy in human immunodeficiency virus-infected patients: protease inhibitors, non-nucleoside reverse transcriptase inhibitors, and nucleotide reverse transcriptase inhibitors.
    Tavel JA; Miller KD; Masur H
    Clin Infect Dis; 1999 Mar; 28(3):643-76. PubMed ID: 10194094
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonnucleoside reverse transcriptase inhibitors.
    Murphy RL
    AIDS Clin Care; 1997 Oct; 9(10):75-7, 79. PubMed ID: 11364757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination treatment -- study results.
    Treat Rev; 1996 Dec; (No 23):4-11. PubMed ID: 11364282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The year in review: antiretroviral treatment.
    Hirschel B; Opravil M
    AIDS; 1999; 13 Suppl A():S177-87. PubMed ID: 10885775
    [No Abstract]   [Full Text] [Related]  

  • 6. Considerations on the effectiveness of nevirapine in protease inhibitor-based regimen simplification.
    Martínez E; Gatell JM
    AIDS; 2007 Aug; 21(13):1829-30. PubMed ID: 17690588
    [No Abstract]   [Full Text] [Related]  

  • 7. Salvage therapy for patients failing their current antiretroviral regimen.
    Albrecht MA
    AIDS Clin Rev; 2000-2001; ():139-91. PubMed ID: 10999220
    [No Abstract]   [Full Text] [Related]  

  • 8. Guidelines for the treatment of HIV.
    Newsline People AIDS Coalit N Y; 1999 Jan; ():31-3. PubMed ID: 11367185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
    Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
    J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
    [No Abstract]   [Full Text] [Related]  

  • 10. Amprenavir study results released.
    AIDS Patient Care STDS; 1999 Dec; 13(12):754. PubMed ID: 10743545
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiretroviral update: recent advances expand options for patients with HIV.
    Santhanam H; Goins M
    Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568
    [No Abstract]   [Full Text] [Related]  

  • 12. Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?
    Cuzin L; Allavena C; Morlat P; Dellamonica P
    AIDS Rev; 2008; 10(4):205-11. PubMed ID: 19092976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switch study of nevirapine.
    AIDS Patient Care STDS; 2000 Dec; 14(12):672. PubMed ID: 11187109
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV-1 protease inhibitors.
    Eron JJ
    Clin Infect Dis; 2000 Jun; 30 Suppl 2():S160-70. PubMed ID: 10860901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The latest antiviral news.
    Vazquez E
    Posit Aware; 1999; 10(2):44. PubMed ID: 11366851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
    Wilkins E
    J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recommendations for antiretroviral treatment in 1998. AIDS Working Group of the Spanish Society for Infectious Diseases and Clinical Microbiology (SEIMC)].
    Moreno S; Arrizabalaga J; Gatell JM; Clotet B; Aguirrebengoa K; Antela A; Iribarren JA; Laguna F; Miró JM; Ocaña I; Rubio R; Viciana P; Podzamczer D
    Enferm Infecc Microbiol Clin; 1998 Oct; 16(8):374-6. PubMed ID: 9835154
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV's potent cocktail.
    Lusky K
    Contemp Longterm Care; 1999 Dec; 22(12):59. PubMed ID: 10977335
    [No Abstract]   [Full Text] [Related]  

  • 19. Standard treatments for HIV, Spring 1997.
    Smith D
    AIDS Treat News; 1997 Apr; (No 269):4-5. PubMed ID: 11364255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibitor + nucleoside reverse transcriptase inhibitor in the randomized ANRS 121 trial.
    Soulié C; Assoumou L; Ghosn J; Duvivier C; Peytavin G; Ait-Arkoub Z; Molina JM; Costagliola D; Katlama C; Calvez V; Marcelin AG
    AIDS; 2009 Jul; 23(12):1605-8. PubMed ID: 19487903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.